| http://www.w3.org/ns/prov#value | - Commitment to Technology-Driven Research and Development The merger of Gilead and NeXstar will bring together two innovative research and development programs, focused on the discovery and development of product candidates for the treatment of serious diseases including infectious diseases and cancer.
|
